TIMENTIN Side Effects

6923662-3 | Thrombocytopenia
on Aug 05, 2010 Male patient from UNITED KINGDOM , 65 years of age, was treated with Timentin (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Timentin dosage: 3.2g Three Times Per Day. During the same period patient was treated with FLUCLOXACILLIN (1g Per Day) (View Flucloxacillin Review and Flucloxacillin Label ), METRONIDAZOLE (500mg Three Times Per Day) (View Metronidazole Review and Metronidazole Label ), PENICILLIN G (1.2g Per Day) (View Penicillin G Review and Penicillin G Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized and became disabled.

6257127-1 | Haemoglobin Decreased, Haemolysis
Patient was taking Timentin (View Usage). Patient had the following side effects: haemoglobin decreased, haemolysis on Jun 25, 2009 from ISRAEL Additional patient health information: Female patient , 80 years of age, . Timentin dosage: .

6252930-6 | Rash Maculo-papular
Adverse event was reported on Jun 29, 2009 by a Male patient taking Timentin (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: CANADA , child 12 years of age, weighting 88.18 lb, After Timentin was administered, patient had the following side effects: rash maculo-papular. During the same period patient was treated with CLOXACILLIN (2000mg Four Times Per Day) (View Cloxacillin Review and Cloxacillin Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), DIPHTHERIA TETANUS VACCINE (NON GSK) (View Diphtheria Tetanus Vaccine (non-gsk) Review and Diphtheria Tetanus Vaccine (non-gsk) Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ).

6190293-5 | Blood Creatinine Increased
on May 04, 2009 Female patient from UNITED STATES , 59 years of age, weighting 240.3 lb, was diagnosed with cellulitis (What is cellulitis?) and was treated with Timentin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased. Timentin dosage: 3.1g Six Times Per Day. During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), NUBAIN (View Nubain Review and Nubain Label ), LOVENOX (40u Per Day) (View Lovenox Review and Lovenox Label ), PROTONIX (View Protonix Review and Protonix Label ), TRAMADOL (View Tramadol Review and Tramadol Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.


6171687-0 | Blood Creatinine Increased
on Apr 21, 2009 Female patient from UNITED STATES , 59 years of age, was diagnosed with cellulitis (What is cellulitis?) and was treated with Timentin (View Usage). Patient had the following side effects: blood creatinine increased. Timentin dosage: 3.1g Six Times Per Day. During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), NUBAIN (View Nubain Review and Nubain Label ), LOVENOX (View Lovenox Review and Lovenox Label ), PROTONIX (View Protonix Review and Protonix Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

5486791-X | Pyrexia
Patient was taking Timentin (View Usage). After Timentin was administered, patient had the following side effects: pyrexia on Oct 10, 2007 from PAKISTAN Additional patient health information: Male patient , 29 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Timentin dosage: . Patient was hospitalized.

5486790-8 | Pyrexia
Adverse event was reported on Oct 10, 2007 by a Male patient taking Timentin (View Usage) (Dosage: ) was diagnosed with sepsis (What is sepsis?) and. Location: PAKISTAN , 40 years of age, Patient experienced the following unwanted or unexpected effects: pyrexia. Patient was hospitalized.

5486782-9 | Pyrexia
on Oct 10, 2007 Male patient from PAKISTAN , 50 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Timentin (View Usage). Patient had the following side effects: pyrexia. Timentin dosage: . During the same period patient was treated with MAXALT (View Maxalt Review and Maxalt Label ), CA SANDOZ (View Ca Sandoz Review and Ca Sandoz Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.

5402707-6 | Psychotic Disorder
on Jul 24, 2007 Female patient from PHILIPPINES , child 8 years of age, was diagnosed with prophylaxis and was treated with Timentin (View Usage). After Timentin was administered, patient had the following side effects: psychotic disorder (What is psychotic disorder?). Timentin dosage: .

5238548-2 | Cardiac Arrest, Haematoma
Patient was taking Timentin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), haematoma on Feb 08, 2007 from GREECE Additional patient health information: Female patient , 80 years of age, . Timentin dosage: . Patient was hospitalized.

5058116-5 | Pneumonia Aspiration
Adverse event was reported on May 25, 2006 by a Male patient taking Timentin (View Usage) (Dosage: 3.1g Three Times Per Day) was diagnosed with pneumonia (What is pneumonia?) and. Location: INDIA , 60 years of age, Patient had the following side effects: pneumonia aspiration. During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ), METROGYL (View Metrogyl Review and Metrogyl Label ), AMPICILLIN SODIUM/SULBACTAM SODIUM (View Ampicillin Sodium/sulbactam Sodium Review and Ampicillin Sodium/sulbactam Sodium Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ).

5026655-9 | Arthralgia, Pyrexia, Rash, Serum Sickness
on Jun 13, 2006 Female patient from CANADA , 66 years of age, was treated with Timentin (View Usage). After Timentin was administered, patient had the following side effects: arthralgia, pyrexia, rash (What is rash?), serum sickness. Timentin dosage: 3.1g Four Times Per Day. During the same period patient was treated with ATARAX (View Atarax Review and Atarax Label ), ATROVENT (View Atrovent Review and Atrovent Label ), CALCIUM + VITAMIN D (View Calcium + Vitamin D Review and Calcium + Vitamin D Label ), CIPRO (View Cipro Review and Cipro Label ), COLACE (View Colace Review and Colace Label ), ELAVIL (View Elavil Review and Elavil Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ).

5026654-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Hepatic Enzyme Increased
on Jun 13, 2006 Male patient from CANADA , 40 years of age, was treated with Timentin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic enzyme increased. Timentin dosage: 3.1g Twice Per Day. During the same period patient was treated with GENTAMICIN (80mg Alternate Days) (View Gentamicin Review and Gentamicin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ARANESP (View Aranesp Review and Aranesp Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), CIPRO (View Cipro Review and Cipro Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), GRAVOL TAB (View Gravol Tab Review and Gravol Tab Label ), HEPARIN (View Heparin Review and Heparin Label ).

5026653-5 | Condition Aggravated, Hyperbilirubinaemia, Jaundice Cholestatic
Patient was taking Timentin (View Usage). Patient had the following side effects: condition aggravated, hyperbilirubinaemia, jaundice cholestatic on Jun 13, 2006 from CANADA Additional patient health information: Male patient , 58 years of age, . Timentin dosage: 3.1g Four Times Per Day. During the same period patient was treated with DILAUDID (View Dilaudid Review and Dilaudid Label ), GRAVOL TAB (View Gravol Tab Review and Gravol Tab Label ), HEPARIN (View Heparin Review and Heparin Label ), MORPHINE (View Morphine Review and Morphine Label ).

5013662-5 | Condition Aggravated, Pneumonia
Adverse event was reported on May 25, 2006 by a Male patient taking Timentin (View Usage) (Dosage: 3.1g Three Times Per Day) was diagnosed with pneumonia aspiration and. Location: INDIA , 60 years of age, After Timentin was administered, patient had the following side effects: condition aggravated, pneumonia (What is pneumonia?). During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ), METROGYL (View Metrogyl Review and Metrogyl Label ), AMPICILLIN SODIUM/SULBACTAM SODIUM (View Ampicillin Sodium/sulbactam Sodium Review and Ampicillin Sodium/sulbactam Sodium Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ).

4939953-1 | Anaphylactic Shock, Blood Pressure Decreased, Loss Of Consciousness
on Mar 03, 2006 Female patient from GREECE , 78 years of age, was diagnosed with ileus and was treated with Timentin (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, blood pressure decreased, loss of consciousness. Timentin dosage: .

4939927-0 | Abdominal Mass, Leukopenia, Thrombocytopenia
on Feb 19, 2006 Female patient from GREECE , 42 years of age, was diagnosed with abdominal abscess and was treated with Timentin (View Usage). Patient had the following side effects: abdominal mass, leukopenia, thrombocytopenia. Timentin dosage: 3.2g Three Times Per Day. During the same period patient was treated with ZANTAC (View Zantac Review and Zantac Label ), FLAGYL (View Flagyl Review and Flagyl Label ), AMINOGLYCOSIDE (View Aminoglycoside Review and Aminoglycoside Label ). Patient was hospitalized.

4938320-4 | Blood Pressure Decreased, Loss Of Consciousness, Syncope
Patient was taking Timentin (View Usage). After Timentin was administered, patient had the following side effects: blood pressure decreased, loss of consciousness, syncope on Mar 02, 2006 from GREECE Additional patient health information: Male patient , 75 years of age, was diagnosed with lower respiratory tract infection and. Timentin dosage: 5.2g See Dosage Text.

4922602-6 | Dysphonia, Dyspnoea, Laryngeal Oedema
Adverse event was reported on Feb 17, 2006 by a Male patient taking Timentin (View Usage) (Dosage: 5.2u Three Times Per Day) was diagnosed with prophylaxis and. Location: GREECE , 78 years of age, Patient experienced the following unwanted or unexpected effects: dysphonia, dyspnoea, laryngeal oedema.

4868373-3 | Muscular Weakness
on Dec 02, 2005 Male patient from CANADA , 83 years of age, was diagnosed with pneumonia (What is pneumonia?), myasthenia gravis and was treated with Timentin (View Usage). Patient had the following side effects: muscular weakness. Timentin dosage: 3.1g Four Times Per Day. During the same period patient was treated with VANCOMYCIN (1000mg Twice Per Day) (View Vancomycin Review and Vancomycin Label ), AZATHIOPRINE (50mg Twice Per Day) (View Azathioprine Review and Azathioprine Label ), PYRIDOSTIGMINE BROMIDE (60mg Four Times Per Day) (View Pyridostigmine Bromide Review and Pyridostigmine Bromide Label ). Patient was hospitalized.

4821505-5 | Haematuria, Pain, Urinary Retention
on Oct 31, 2005 Male patient from UNITED KINGDOM , 71 years of age, weighting 140.7 lb, was diagnosed with neutropenic sepsis, lymphoma (What is lymphoma?), atrial fibrillation (What is atrial fibrillation?), gastritis and was treated with Timentin (View Usage). After Timentin was administered, patient had the following side effects: haematuria, pain (What is pain?), urinary retention. Timentin dosage: . During the same period patient was treated with GENTAMICIN (300mg Per Day) (View Gentamicin Review and Gentamicin Label ), PREDNISOLONE (10mg Per Day) (View Prednisolone Review and Prednisolone Label ), SOTALOL (40mg Twice Per Day) (View Sotalol Review and Sotalol Label ), LANSOPRAZOLE (30mg Per Day) (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

4810252-1 | Pruritus, Purpura
Patient was taking Timentin (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, purpura on Oct 13, 2005 from FRANCE Additional patient health information: Male patient , 60 years of age, was diagnosed with infection (What is infection?) and. Timentin dosage: 12g Per Day. During the same period patient was treated with AMIKLIN (1g Per Day) (View Amiklin Review and Amiklin Label ), FLAGYL (1.5g Per Day) (View Flagyl Review and Flagyl Label ), BEFIZAL (View Befizal Review and Befizal Label ). Patient was hospitalized.

4804442-1 | Candida Sepsis, Erythema, Haemorrhage, Hyperkalaemia, Hyperphosphataemia, Infection, Mucous Membrane Disorder, Pain Of Skin, Renal Failure Acute
Adverse event was reported on Oct 10, 2005 by a Male patient taking Timentin (View Usage) (Dosage: 5g Three Times Per Day) . Location: FRANCE , 41 years of age, weighting 172.0 lb, Patient had the following side effects: candida sepsis, erythema, haemorrhage, hyperkalaemia, hyperphosphataemia, infection (What is infection?), mucous membrane disorder, pain of skin, renal failure acute. During the same period patient was treated with PRIMPERAN INJ (10mg Three Times Per Day) (View Primperan Inj Review and Primperan Inj Label ), TRANXENE (10mg Three Times Per Day) (View Tranxene Review and Tranxene Label ), OFLOCET (400mg Twice Per Day) (View Oflocet Review and Oflocet Label ), FLUCONAZOLE (800mg Per Day) (View Fluconazole Review and Fluconazole Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ).

4792474-1 | Cholangitis, Cholestasis, Jaundice, Liver Disorder
on Sep 29, 2005 Male patient from FRANCE , 35 years of age, was treated with Timentin (View Usage). After Timentin was administered, patient had the following side effects: cholangitis, cholestasis, jaundice (What is jaundice?), liver disorder. Timentin dosage: 5g Three Times Per Day. During the same period patient was treated with ZELITREX (View Zelitrex Review and Zelitrex Label ), NEORAL (View Neoral Review and Neoral Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), MOPRAL (View Mopral Review and Mopral Label ), IMOVANE (View Imovane Review and Imovane Label ), ORACILLINE (View Oracilline Review and Oracilline Label ). Patient was hospitalized.

4734766-8 | Biliary Tract Operation, Cholelithiasis, Hepatitis Cholestatic, Jaundice, Pruritus
on Jul 26, 2005 Female patient from FRANCE , 82 years of age, was diagnosed with superinfection lung and was treated with Timentin (View Usage). Patient experienced the following unwanted or unexpected effects: biliary tract operation, cholelithiasis, hepatitis cholestatic, jaundice (What is jaundice?), pruritus. Timentin dosage: . During the same period patient was treated with SERETIDE (View Seretide Review and Seretide Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), PLAVIX (View Plavix Review and Plavix Label ), BACTRIM (View Bactrim Review and Bactrim Label ), COTAREG (View Cotareg Review and Cotareg Label ). Patient was hospitalized.

4730023-4 | Rash
Patient was taking Timentin (View Usage). Patient had the following side effects: rash (What is rash?) on Jul 28, 2005 from UNITED STATES Additional patient health information: Male patient , 58 years of age, was diagnosed with cellulitis (What is cellulitis?), diabetes mellitus and. Timentin dosage: 31g Q8h.

4716015-X | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Liver Function Test Abnormal, Rash
Adverse event was reported on Jul 06, 2005 by a Male patient taking Timentin (View Usage) (Dosage: ) was diagnosed with neuropathy peripheral, prophylaxis, infected skin ulcer and. Location: AUSTRALIA , 57 years of age, After Timentin was administered, patient had the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, liver function test abnormal, rash (What is rash?). During the same period patient was treated with RUBOXISTAURIN MESYLATE (32mg Per Day) (View Ruboxistaurin Mesylate Review and Ruboxistaurin Mesylate Label ), ATACAND (View Atacand Review and Atacand Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), MIXTARD HUMAN 70/30 (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ), CLINDAMYCIN (1200mg Per Day) (View Clindamycin Review and Clindamycin Label ).

4677094-1 | Thrombocytopenia
on May 25, 2005 Male patient from , 77 years of age, weighting 187.8 lb, was treated with Timentin (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Timentin dosage: . Patient was hospitalized.

4673432-4 | Activated Partial Thromboplastin Time Abnormal, Condition Aggravated, Disease Progression, Disseminated Intravascular Coagulation, Hepatic Failure, Hyperkalaemia, Hypoalbuminaemia, Hypocalcaemia, Hypokalaemia
on May 20, 2005 Female patient from , 69 years of age, weighting 163.1 lb, was diagnosed with ill-defined disorder, breast cancer (What is breast cancer?) and was treated with Timentin (View Usage). Patient had the following side effects: activated partial thromboplastin time abnormal, condition aggravated, disease progression, disseminated intravascular coagulation, hepatic failure, hyperkalaemia, hypoalbuminaemia, hypocalcaemia, hypokalaemia. Timentin dosage: . During the same period patient was treated with DOXIL (30mgm2 Cyclic) (View Doxil Review and Doxil Label ), TAXOTERE (60mgm2 Cyclic) (View Taxotere Review and Taxotere Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), ANTIBIOTIC (View Antibiotic Review and Antibiotic Label ), VITAMIN B6 (200mg Per Day) (View Vitamin B6 Review and Vitamin B6 Label ). Patient was hospitalized.

4672577-2 | Accidental Overdose, Anaemia, Anaemia Neonatal, Haematuria, Haptoglobin Decreased, Hyponatraemia, Leukopenia Neonatal, Metabolic Acidosis
Patient was taking Timentin (View Usage). After Timentin was administered, patient had the following side effects: accidental overdose, anaemia, anaemia neonatal, haematuria, haptoglobin decreased, hyponatraemia, leukopenia neonatal, metabolic acidosis on Jan 09, 2001 from Additional patient health information: Male patient , weighting 2.87 lb, was diagnosed with enterocolitis and. Timentin dosage: . During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

4667319-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Liver Function Test Abnormal, Nephritis
Adverse event was reported on May 19, 2005 by a Male patient taking Timentin (View Usage) (Dosage: 3.1 G Ivpb Q 6h) was diagnosed with bacteraemia and. Location: , 43 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, liver function test abnormal, nephritis. Patient was hospitalized.

4660439-6 | Prothrombin Level Decreased
on May 10, 2005 Female patient from , 20 years of age, was diagnosed with ill-defined disorder and was treated with Timentin (View Usage). Patient had the following side effects: prothrombin level decreased. Timentin dosage: 3.1g Six Times Per Day. During the same period patient was treated with CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), HEPARIN (2500unit Twice Per Day) (View Heparin Review and Heparin Label ), LOSEC (View Losec Review and Losec Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

4658674-6 | Hepatotoxicity
on May 10, 2005 Female patient from , 79 years of age, was diagnosed with febrile neutropenia and was treated with Timentin (View Usage). After Timentin was administered, patient had the following side effects: hepatotoxicity. Timentin dosage: 3.1 Gm Q6h Intravenou. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), VITAMIN K (View Vitamin K Review and Vitamin K Label ), MILK OF MAGNESIA (View Milk Of Magnesia Review and Milk Of Magnesia Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), LOVENOX (View Lovenox Review and Lovenox Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ). Patient was hospitalized.

4632221-7 | Early Menarche
Patient was taking Timentin (View Usage). Patient experienced the following unwanted or unexpected effects: early menarche on Jun 21, 2004 from Additional patient health information: Female patient , 50 years of age, was diagnosed with cellulitis (What is cellulitis?) and. Timentin dosage: 3.1g Three Times Per Day. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ).

4605209-X | Chills, Coma, Hyperhidrosis, Musculoskeletal Stiffness, Tachypnoea, Tremor
Adverse event was reported on Mar 10, 2005 by a Male patient taking Timentin (View Usage) (Dosage: 2 Grams Q 8 H Iv) . Location: , 84 years of age, Patient had the following side effects: chills, coma, hyperhidrosis, musculoskeletal stiffness, tachypnoea, tremor.

4578036-X | Neutrophil Count Decreased, White Blood Cell Count Decreased
on Feb 03, 2005 Male patient from , 53 years of age, weighting 126.0 lb, was diagnosed with lobar pneumonia and was treated with Timentin (View Usage). After Timentin was administered, patient had the following side effects: neutrophil count decreased, white blood cell count decreased. Timentin dosage: 3.1gm Q6h Intravenous. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), GUAIFENESIN (View Guaifenesin Review and Guaifenesin Label ), HEPARIN (View Heparin Review and Heparin Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), PREVACID (View Prevacid Review and Prevacid Label ), LEVYTHYROXINE (View Levythyroxine Review and Levythyroxine Label ). Patient was hospitalized.